| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0301736.5AGB0301736D0 (en) | 2003-01-24 | 2003-01-24 | Pharmaceutical compounds |
| PCT/GB2004/000274WO2004065389A1 (en) | 2003-01-24 | 2004-01-23 | Pyrrolopyrimidine derivatives useful as modulators of multidrug resistance |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0301736.5AGB0301736D0 (en) | 2003-01-24 | 2003-01-24 | Pharmaceutical compounds |
| Publication Number | Publication Date |
|---|---|
| GB0301736D0true GB0301736D0 (en) | 2003-02-26 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0301736.5ACeasedGB0301736D0 (en) | 2003-01-24 | 2003-01-24 | Pharmaceutical compounds |
| Country | Link |
|---|---|
| GB (1) | GB0301736D0 (en) |
| WO (1) | WO2004065389A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050171094A1 (en)* | 2002-02-22 | 2005-08-04 | Kenichiro Kataoka | Pyrrolopyrimidine derivatives |
| AU2007293773B2 (en) | 2006-09-07 | 2013-01-31 | Albert Einstein College Of Medicine, Inc. | Acyclic amine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase |
| KR101433621B1 (en) | 2006-09-07 | 2014-08-27 | 알버트 아인슈타인 컬리지 오브 메디신 오브 예쉬바 유니버시티 | Non-cyclic amine inhibitors of nucleoside phosphorylase and hydrolase |
| TW201204733A (en) | 2010-06-25 | 2012-02-01 | Kowa Co | Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same |
| CN102532006A (en)* | 2012-01-31 | 2012-07-04 | 江西华士药业有限公司 | Preparation method of key intermediate 6-methylpyridine-3-formaldehyde of drug for treating rheumatic arthritis and rheumatoid arthritis |
| CA2938476A1 (en)* | 2014-02-20 | 2015-08-27 | Glaxosmithkline Intellectual Property (No.2) Limited | Pyrrolo[3,2-d]pyrimidine derivatives as inducers of human interferon |
| US10995066B1 (en)* | 2019-11-26 | 2021-05-04 | Therasid Bioscience Inc. | Method for preparing novel crystalline forms of 1-(4-benzyloxy-benzyl)-3-methyl-thiourea |
| US20230322788A1 (en)* | 2020-08-05 | 2023-10-12 | Beigene, Ltd. | Imidazotriazine and pyrrolopyrimidine derivatives as kras g12c inhibitors |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW527186B (en)* | 1996-03-19 | 2003-04-11 | Janssen Pharmaceutica Nv | Fused imidazole derivatives as multidrug resistance modulators |
| Publication number | Publication date |
|---|---|
| WO2004065389A1 (en) | 2004-08-05 |
| Publication | Publication Date | Title |
|---|---|---|
| EG27104A (en) | Pharmaceutical compounds | |
| GB0315657D0 (en) | Pharmaceutical compounds | |
| GB0218625D0 (en) | Pharmaceutical compounds | |
| GB0324886D0 (en) | Medicinal compounds | |
| GB0303396D0 (en) | Medicinal compounds | |
| GB0308511D0 (en) | Pharmaceutical compounds | |
| HU0301154D0 (en) | Pharmaceutical composition | |
| GB0300427D0 (en) | Pharmaceutical composition | |
| GB0215775D0 (en) | Pharmaceutical compounds | |
| GB0307866D0 (en) | Pharmaceutical composition | |
| EP1699458A4 (en) | Pharmaceutical composition | |
| GB0329232D0 (en) | Pharmaceutical composition | |
| GB0317663D0 (en) | Pharmaceutical composition | |
| GB0317315D0 (en) | Pharmaceutical compounds | |
| GB0328490D0 (en) | Medicinal compounds | |
| GB0313766D0 (en) | Pharmaceutical compounds | |
| GB0316889D0 (en) | Pharmaceutical agents | |
| EP1778252A4 (en) | Noncardiotoxic pharmaceutical compounds | |
| GB0300885D0 (en) | Pharmaceutical composition | |
| GB0301736D0 (en) | Pharmaceutical compounds | |
| GB2401043B (en) | Drug | |
| GB0306933D0 (en) | Pharmaceutical composition | |
| GB0329617D0 (en) | Pharmaceutical compounds | |
| GB0307869D0 (en) | Pharmaceutical composition | |
| GB0310361D0 (en) | Pharmaceutical compound |
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |